Promoting Efficacy of Human Platelet Lysate on Proliferation of Mammalian Cell Lines Used for Vaccine Production

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Aly N.I.; Fahmy H.M.; Atta O.; Elzallat M.; Abass A.M.; Abu-Taleb H.

Journal: Journal of Advanced Veterinary Research

Publisher: Assiut University, Faculty of Veterinary Medicine, Department of Animal Medicine

Publication Date: 2023

Volume / Issue: Volume 13 / Issue 6

Pages: 1157–1160

ISSN: 20906269

Scopus: View on Scopus

Document Type: Article


Authors and Affiliations

Aly N.I., Agriculture Research Center (ARC), Veterinary Serum and Vaccine Research Institute (VSVRI), Abasia, Cairo, Egypt; Fahmy H.M., Laboratory and Transfusion Medicine, Ain Shams Medical School, Cairo, Egypt; Atta O., Agriculture Research Center (ARC), Veterinary Serum and Vaccine Research Institute (VSVRI), Abasia, Cairo, Egypt; Elzallat M., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Abass A.M., Agriculture Research Center (ARC), Veterinary Serum and Vaccine Research Institute (VSVRI), Abasia, Cairo, Egypt; Abu-Taleb H., Environmental Research Department, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

The current study was conducted to determine to what extent human platelet lysate (HPL) can be used to enhance the growth of three cell lines used for propagation of Bovine Ephemeral Fever Virus (BEFV) and Rabies virus (RV) for vaccine production. HPL; Fetal Calf Serum (FCS) and Newborn Calf Serum (NBCS) were used as supplements to the used cell culture medium (Minimum Essential Medium “MEM”) for passaging of three cell lines including baby hamster kidney (BHK-21); African green monkey kidney (VERO) and Madin Derby canine kidney (MDCK). Through three successive cell culture passages; for each cell line; it was found that HPL supported growth and propagation of BHK-21, VERO and MDCK cell lines without altering their morphologic and functional characteristics. It has been accepted as a suitable alternative to FBS and NBCS, and it can be used in vaccinal production. © 2011-2023 Journal of Advanced Veterinary Research. All rights reserved.


Keywords

Cell culture; Growth factor; Human Platelet Lysate (HPL)


Citation Information

Scopus Citations: 2


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer